Download
ijerph-17-03638.pdf 8,33MB
WeightNameValue
1000 Titel
  • The Contribution of Spanish Science to Patents: Medicine as Case of Study
1000 Autor/in
  1. Cascajares Rupérez, Mila |
  2. Alcayde García, Alfredo |
  3. Garrido Cárdenas, José Antonio |
  4. Manzano-Agugliaro, Francisco |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-05-21
1000 Erschienen in
1000 Quellenangabe
  • 17(10):3638
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3390/ijerph17103638 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277902/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Investments in research and development (R&D) and innovation are expensive, and one wishes to be assured that there is positive feedback and to receive guidance on how to direct investments in the future. The social or economic benefits of investments in R&D are of particular interest to policymakers. In this regard, public expense in research, especially through universities, is sometimes being questioned. This paper establishes a measure of how research in Spain, and specifically in its universities, is involved. In this study, we have analyzed all the literature cited in the period 1998–2018 produced by Spanish institutions and which has been cited in at least one international patent, obtaining more than 40,000 publications from more than 160,000 different authors. The data have been surprisingly positive, showing that practically all public universities contribute to this subject and that there is a great deal of international collaboration, both in terms of the number of countries with which they collaborate and the prestige of the institutions involved. Regarding the specific scientific fields in which this collaboration is most relevant, biochemistry, genetics and molecular biology, and medicine together account for almost 40% of the total works. The topics most used by these publications were those of diseases or medical problems such as: Neoplams, Carcinoma, Alzheimer Disease, or human immunodeficiency virus (HIV-1). Oncology was according to the All Science Journal Classification (ASJC) the leading and central issue. Therefore, although the result of basic research is difficult to quantify, when it is observed that there is a return in fields such as medicine or global health, it can be said that it is well employed. In terms of journals from a purely bibliometric point of view, it has been observed that some journals do not have a great impact or relative position within their categories, but they do have a great relevance in this area of patent support. Therefore, it would be worthwhile to set up a rank for scientific journals based on the citations of patents, so the percentage of articles cited in patents with Field-Weighted Citation Impact (FWCI) >1, and as an indicator of scientific transfer from universities or research centres, the transference index in patents (TIP) is also proposed.
1000 Sacherschließung
lokal Research and Development
lokal bibliometrics
lokal patents
lokal social returns
lokal Scival
lokal Spain
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-2973-656X|https://orcid.org/0000-0002-2776-089X|https://orcid.org/0000-0002-2785-0027|https://orcid.org/0000-0002-0085-030X
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6435351.rdf
1000 Erstellt am 2022-10-07T11:23:47.139+0200
1000 Erstellt von 329
1000 beschreibt frl:6435351
1000 Bearbeitet von 329
1000 Zuletzt bearbeitet 2022-11-11T18:29:29.984+0100
1000 Objekt bearb. Fri Nov 11 18:29:29 CET 2022
1000 Vgl. frl:6435351
1000 Oai Id
  1. oai:frl.publisso.de:frl:6435351 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source